Apeloa Pharmaceutical Co.,Ltd (SHE:000739)

Market Cap	19.93B +10.7%
Revenue (ttm)	9.78B -18.6%
Net Income	890.68M -13.6%
EPS	0.77 -12.9%
Shares Out	1.13B
PE Ratio	22.92
Forward PE	18.78
Dividend	0.48 (2.70%)
Ex-Dividend Date	Sep 17, 2025

Volume	8,730,560
Average Volume	8,710,708
Open	18.00
Previous Close	17.70
Day's Range	17.66 - 18.39
52-Week Range	12.96 - 19.59
Beta	0.38
RSI	49.57
Earnings Date	Mar 20, 2026

About SHE:000739

Apeloa Pharmaceutical Co.,Ltd provides raw materials various pharmaceutical factories in the People’s Republic of China and internationally. The company operates through API, CDMO, and Pharmaceutical segments. It offers API intermediates business, which includes cephalosporin, penicillin, psychotropic, cardiovascular and cerebrovascular, and veterinary API intermediates series; innovative drug R&D and production services CDMO include R&D services, commercial human drug projects, commercial veterinary drug projects and other commercial projects;...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1989
• Employees: 6,787
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000739

Financial Performance

In 2025, SHE:000739's revenue was 9.78 billion, a decrease of -18.62% compared to the previous year's 12.02 billion. Earnings were 890.68 million, a decrease of -13.62%.